147 related articles for article (PubMed ID: 6826327)
1. Role of complement in murine corneal infection caused by Pseudomonas aeruginosa.
Cleveland RP; Hazlett LD; Leon MA; Berk RS
Invest Ophthalmol Vis Sci; 1983 Feb; 24(2):237-42. PubMed ID: 6826327
[TBL] [Abstract][Full Text] [Related]
2. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
Hazlett LD; McClellan S; Kwon B; Barrett R
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
[TBL] [Abstract][Full Text] [Related]
3. C3 dependent, C5 independent immune complex glomerulopathy in the mouse.
Sawtell NM; Hartman AL; Weiss MA; Pesce AJ; Michael JG
Lab Invest; 1988 Mar; 58(3):287-93. PubMed ID: 2964544
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
5. Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.
Hazlett LD; Huang X; McClellan SA; Barrett RP
Eye (Lond); 2003 Nov; 17(8):863-71. PubMed ID: 14631390
[TBL] [Abstract][Full Text] [Related]
6. Experimental Escherichia coli 06 infection in mice. IV. On the relative importance of complement factors and antibodies for the host defence.
Ahlstedt S
Acta Pathol Microbiol Scand C; 1981 Feb; 89(1):23-8. PubMed ID: 7027735
[TBL] [Abstract][Full Text] [Related]
7. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis.
Huang X; Du W; McClellan SA; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4910-6. PubMed ID: 17065506
[TBL] [Abstract][Full Text] [Related]
8. Corneal response to Pseudomonas aeruginosa infection.
Hazlett LD
Prog Retin Eye Res; 2004 Jan; 23(1):1-30. PubMed ID: 14766315
[TBL] [Abstract][Full Text] [Related]
9. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
Cunnion KM; Benjamin DK; Hester CG; Frank MM
J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
[TBL] [Abstract][Full Text] [Related]
10. The effect of complement depletion on the course of Sindbis virus infection in mice.
Hirsch RL; Griffin DE; Winkelstein JA
J Immunol; 1978 Oct; 121(4):1276-8. PubMed ID: 701795
[TBL] [Abstract][Full Text] [Related]
11. Serum antibody and ocular responses to murine corneal infection caused by Pseudomonas aeruginosa.
Berk RS; Montgomery IN; Hazlett LD
Infect Immun; 1988 Dec; 56(12):3076-80. PubMed ID: 3141279
[TBL] [Abstract][Full Text] [Related]
12. Antibody hyporesponsiveness in resistant BALB/cJ mice intracorneally infected with Pseudomonas aeruginosa.
Berk RS; Preston M; Montgomery IN; Hazlett LD; Tse HY
Reg Immunol; 1990-1991; 3(4):186-92. PubMed ID: 2129603
[TBL] [Abstract][Full Text] [Related]
13. Association of CD4+ T cell-dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa ocular infection.
Kwon B; Hazlett LD
J Immunol; 1997 Dec; 159(12):6283-90. PubMed ID: 9550433
[TBL] [Abstract][Full Text] [Related]
14. Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection.
Hazlett LD; Rudner XL; McClellan SA; Barrett RP; Lighvani S
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):419-24. PubMed ID: 11818386
[TBL] [Abstract][Full Text] [Related]
15. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation.
Kernacki KA; Barrett R; Hazlett LD
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.
McClellan SA; Huang X; Barrett RP; Lighvani S; Zhang Y; Richiert D; Hazlett LD
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):256-64. PubMed ID: 16384971
[TBL] [Abstract][Full Text] [Related]
17. Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5.
Hodgetts SI; Grounds MD
Immunol Cell Biol; 2001 Jun; 79(3):231-9. PubMed ID: 11380675
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies provide protection against ocular Pseudomonas aeruginosa infection.
Moon MM; Hazlett LD; Hancock RE; Berk RS; Barrett R
Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1277-84. PubMed ID: 2843483
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma musculi infections in normocomplementemic, C5-deficient, and C3-depleted mice.
Jarvinen JA; Dalmasso AP
Infect Immun; 1977 May; 16(2):557-63. PubMed ID: 863515
[TBL] [Abstract][Full Text] [Related]
20. Substance P regulates natural killer cell interferon-gamma production and resistance to Pseudomonas aeruginosa infection.
Lighvani S; Huang X; Trivedi PP; Swanborg RH; Hazlett LD
Eur J Immunol; 2005 May; 35(5):1567-75. PubMed ID: 15832292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
